References
- Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K. Recurrence of meningiomas. Cancer 2000;89:1102–10.
- Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J. Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999;90:455–62.
- Ildan F, Erman T, Göçer AI, . Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 2007;17:157–71.
- Louis DN, Scheithauer BW, Budka H. Meningiomas. In: Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system: World Health Organisation classification of tumours. Lyon: IARC Press, 2000:176–84.
- Norden AD, Drappatz J, Wen PY. Advances in meningioma therapy. Curr Neurol Neurosci Rep 2009;9:231–40.
- Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 2004; 363:1535–43.
- Maiuri F, De Caro Mdel B, Esposito F, . Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 2007;82:63–8.
- Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004;63:275–86.
- Lusis EA, Chicoine MR, Perry A. High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 2005;73:219–23.
- Roser F, Samii M, Ostertag H, Bellinzona M. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 2004;146:37–44; discussion 44.
- Abdelzaher E, El-Gendi SM, Yehya A, Gowil AG. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg 2010 Oct 27. [Epub ahead of print]